纽泰克斯医疗

最新新闻

• Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $200
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  Lake Street Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $235
  \u5e02\u573a\u8d44\u8baf · 2026/6/2
• Lake Street Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $310
  \u5e02\u573a\u8d44\u8baf · 2026/8/11
• 评级变动
  Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Cuts Target Price to $205
  \u5e02\u573a\u8d44\u8baf · 2025/8/26
• 评级变动
  Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Maintains Target Price $150
  \u5e02\u573a\u8d44\u8baf · 2025/5/14
• 评级变动
  Benchmark Co. Reaffirms Their Buy Rating on Clinigence Holdings (NUTX)
  TipRanks · 2025/9/3
• Lake Street Maintains Nutex Health(NUTX.US) With Buy Rating, Maintains Target Price $310
  \u5e02\u573a\u8d44\u8baf · 2026/8/13
• 评级变动
  Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Maintains Target Price $175
  \u5e02\u573a\u8d44\u8baf · 2026/5/5
• 评级变动
  Analysts Offer Insights on Healthcare Companies: Artiva Biotherapeutics, Inc. (ARTV) and Clinigence Holdings (NUTX)
  TipRanks · 2026/3/11
• 评级变动
  Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $300
  \u5e02\u573a\u8d44\u8baf · 2025/5/15
• 评级变动
  Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $175
  \u5e02\u573a\u8d44\u8baf · 2026/5/3
• 评级变动
  Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Cuts Target Price to $150
  \u5e02\u573a\u8d44\u8baf · 2026/3/11
• 评级变动
  Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $230
  \u5e02\u573a\u8d44\u8baf · 2025/11/26
• 评级变动
  Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Maintains Target Price $300
  \u5e02\u573a\u8d44\u8baf · 2026/3/10
• 评级变动
  TR | OpenAI - 4o Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $103
  \u5e02\u573a\u8d44\u8baf · 2025/8/24
• 评级变动
  TR | OpenAI - 4o Downgrades Nutex Health(NUTX.US) to Hold Rating, Cuts Target Price to $100
  \u5e02\u573a\u8d44\u8baf · 2025/8/26
• 评级变动
  Maxim Group Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $225
  \u5e02\u573a\u8d44\u8baf · 2025/5/21
• B. Riley Securities Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $325
  \u5e02\u573a\u8d44\u8baf · 2026/9/4
• 评级变动
  Benchmark Co. Maintains Nutex Health(NUTX.US) With Buy Rating, Raises Target Price to $150
  \u5e02\u573a\u8d44\u8baf · 2025/4/9
• B. Riley Securities Initiates Nutex Health(NUTX.US) With Buy Rating, Announces Target Price $290
  \u5e02\u573a\u8d44\u8baf · 2026/6/26

新闻标题为自动聚合内容，未经我们团队独立核实或编辑。